Understanding the complex relationship between CXCL10, the JAK-STAT pathway and immune checkpoints provide valuable insights for the development of targeted therapies aimed at reprogramming the tumor microenvironment and improving cancer treatment outcomes.62 The gene discussed is SOAT1; the disease is neoplasm.